RARE vs SMTC · rev $350.0M vs rev $1.05B
Ultragenyx (RARE) versus Semtech Corporation (SMTC) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Semtech Corporation (SMTC) is a semiconductors company listed on US.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
Latest reported SMTC revenue for 2026-01-25 was $1.05B. Net income was -$40.4M. Revenue was up 15.5% from 2025-01-26 to 2026-01-25. SMTC currently screens at market cap $14.07B.
RARE currently screens at market cap $2.79B. SMTC currently screens at market cap $14.07B.
Not investment advice. Open the RARE and SMTC stock pages for the full models.
Not investment advice.